DKmedtech Re-Selected for 2024 China Biopharma Front-Runners 100 – Excellence Leader List

DK Medical Technology Co., Ltd. (hereinafter referred to as "DK Medtech") was founded in 2015 by Mr. Weng Yulin and is headquartered in Suzhou City, Jiangsu Province. DK Medtech is committed to improving patients' quality of life through leading technology and innovative medical solutions. Its current product lines cover areas such as coronary intervention, peripheral intervention, and neurointervention, aiming to provide high-quality medical solutions for patients worldwide.

Since its establishment, DK Medtech has always adhered to innovation as its driving force and has now become a leading Chinese full-category vascular interventional innovation enterprise. It has developed more than ten types of balloon products, including plain balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Its product line covers almost all vascular interventional fields, including cardiovascular intervention, peripheral intervention, and neurointervention. Through its self-developed directional scoring technology, which is applied in coronary scoring balloons, peripheral scoring balloons, and drug-coated scoring balloons, the company’s clinical performance, based on published pre-market RCT studies, shows significantly better clinical benefits compared to imported control groups. DK Medtech has achieved excellent results and market status in niche markets and signed multiple strategic cooperation agreements with well-known foreign companies such as Medtronic and Asahi Intecc.

DK Medtech has built a team of over 300 people covering R&D, operations, management, and sales, with a 12,000㎡ global manufacturing center and a 9,200㎡ R&D office center. To date, DK Medtech has been honored as a "National Specialized, Professional, Unique, and Innovative Little Giant Enterprise," "National High-tech Enterprise," "Jiangsu Province Potential Unicorn Enterprise," "Suzhou Unicorn Cultivation Enterprise," "Suzhou Engineering Technology Center," VB "Top 100 Future Healthcare Companies in 2024," "2024 Medical Health Industry Innovation Power Product List," "China Medical Device 2024 Star Exploration Innovation List," "Top 100 Sharp Companies of CV Awards 2023," "Venture50 (Influential List, Life & Health List) 2023," and ranked among the top 14 in the 8th China Innovation and Entrepreneurship Competition. The company holds certifications including ISO:13485 Quality Management System Certification, MDSAP Certification, and Intellectual Property Compliance Management System Certification (GB/T29490-2023). It has also participated in the drafting of several national and industry standards, such as the *Guidelines for Release Parameters of Ethylene Oxide Sterilization Processes for Medical Devices* and *Test Methods for Coating Adhesion of Intravascular Catheter Guide Wires*.

At the same time, the company has been widely favored by social capital. So far, it has gone through six rounds of financing, cumulatively receiving hundreds of millions of yuan in financing from well-known investment institutions such as Qiming Venture Capital, Legend Capital, Oriza Ventures, CICC Capital, and Gaocheng Capital.